Bladder cancer stage and outcome by array-based comparative genomic hybridization. - Wikidata - awgldk - TriplyDB

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

http://www.wikidata.org/entity/Q34456640

about

Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors Alteration of TEAD1 expression levels confers apoptotic resistance through the transcriptional up-regulation of Livin Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype Molecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray Comparison A Hidden Markov Model to estimate population mixture and allelic copy-numbers in cancers using Affymetrix SNP arrays.Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival.Oncodrive-CIS: a method to reveal likely driver genes based on the impact of their copy number changes on expression ACTuDB, a new database for the integrated analysis of array-CGH and clinical data for tumors.Classification of arrayCGH data using fused SVM.A hypergraph-based learning algorithm for classifying gene expression and arrayCGH data with prior knowledge.Urine-based assays for the detection of bladder cancer.Determining frequent patterns of copy number alterations in cancer.Distinct microRNA alterations characterize high- and low-grade bladder cancer Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistance Identification of ALK gene alterations in urothelial carcinoma.Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis.Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis Chromosomal imbalances in human bladder urothelial carcinoma: similarities and differences between biopsy samples and cancer stem-like cells Classification with correlated features: unreliability of feature ranking and solutions.Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.Gain of 5p15.33 is associated with progression of bladder cancer.Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.Stability-based comparison of class discovery methods for DNA copy number profiles.Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinoma Mapping of the chromosomal amplification 1p21-22 in bladder cancer.Molecular biology of bladder cancer.Modelling bladder cancer in mice: opportunities and challenges.The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.Differentiating progressive from nonprogressive T1 bladder cancer by gene expression profiling: applying RNA-sequencing analysis on archived specimens.Genome-wide copy number analysis of cerebrospinal fluid tumor cells and their corresponding archival primary tumors Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression.Detection of DNA copy number alterations in cancer by array comparative genomic hybridization.Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study

P2860

Q21202038-17022C07-065D-40DF-B5E8-F67D14B15C8C Q28276187-CF451AAD-8E62-43BC-930F-68878B167A95 Q28387443-093F944F-49BD-4762-94C9-04207E9C7B6F Q28395447-42A5CE84-92D2-441E-A2DA-33B4442B1723 Q28547625-3A727A91-5AB2-452E-88F9-A1967E5BA864 Q30837295-A53FBD5C-1A3E-415B-9C4E-2E517236FA3C Q31016728-9E0D8A98-9D5B-4723-A6E4-FBA881657871 Q31110904-380DF088-2EB8-4A05-9DE0-F25709581E28 Q31112364-F52B1D6C-0C3E-416E-A6AC-5C7BD298462D Q33347418-63240C17-96EE-47AC-8C61-0328F4D7F195 Q33489270-CC2275B8-BA1A-4DAB-87A3-FB4ACBBAFBDC Q33643957-18A48930-E431-4B54-8E73-E02F22A2A946 Q33658568-AF931836-204A-433E-92E8-A1D45A554123 Q33854463-C225E7D4-569C-4D9D-B2F4-F0EFE4EB47EF Q33941309-2A84E1BC-A955-43FB-96B0-D47AFEE21B94 Q33989002-A452D89A-72FD-4044-8A72-C0D664CB8714 Q34016615-D5708A8D-5E32-4DBC-AD9F-0AF736F846A9 Q34080289-1EC9D58C-419D-490E-A2FC-95EEF7C94A2D Q34174124-0C86DDD8-4970-49C8-9CF4-901013945E84 Q34185282-CDDC4A72-2F01-4CE2-9BEB-39E5D99F28D3 Q34299788-C47090A8-8665-4709-AF0B-2B4D8FA4654F Q34585359-91A52E1F-0CFC-4342-A092-1AFD8A685014 Q34674350-4E2916AE-580A-434A-8F86-B5CA8273056E Q34715467-2CACC9C3-470A-4456-A198-E196812269A8 Q34734078-0B3D2B54-0DB0-4AA5-99F2-6A42E87FA3FA Q34996775-120708FC-E1A3-4435-9849-23A427A58285 Q35067525-D271B0D7-EFA0-495E-AEFA-946F18304977 Q35142587-E53EDF9C-7B17-4504-8B07-08774490137A Q35227493-4956047F-CB53-433F-BD56-7E8C15E775AB Q35266400-02B93A43-885E-4B73-A457-614884BA7A0E Q35285703-06D25371-9429-40C9-AF0E-9416E3166427 Q35638497-9023FA54-0775-489D-8174-D890A2542EEC Q35655215-22567D96-5BB3-4A0F-845A-104042811F7F Q35950754-BEEFCA09-E22A-424B-9BD9-0800EEF7E53A Q35990061-CCAFCF7E-282C-474A-8977-C340D92D66EE Q36187834-636326CF-02AF-430A-B3EA-21E746A58B9F Q36341182-2DDD4301-CA88-429E-8657-2F75404E9C5A Q36659255-8166490A-8CA2-4429-8419-261D12F52D70 Q36943634-86FD6BED-4365-4475-9CF7-7CC03A51840A Q37012918-FB8C623D-27B2-49B9-A657-4BBCAC37E448

P2860

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

http://www.wikidata.org/entity/Q34456640

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

@ast

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

@en

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

@nl

type

label

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

@ast

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

@en

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

@nl

prefLabel

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

@ast

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

@en

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

@nl

P1433

Q34456640-2EEDF568-7CA6-442F-B33C-60BDDEA153E0

P1476

Q34456640-0227A390-C62D-49C4-89BB-4AD7B1411DDC

P2093

Q34456640-11A2BA1A-E43B-4528-A2CD-72C9CA91AD58

Q34456640-51167C1C-2AA5-45F8-A51B-842AD7E90C16

Q34456640-562E57C3-F809-46A5-9E50-D0C7AAA9BB48

Q34456640-74BD8470-6540-4630-B502-AF50C07A7FA3

Q34456640-7FF117A6-0AEC-40B8-9427-942FC7045752

Q34456640-898234AC-069A-4ECA-8B49-C1A8BB9E512A

Q34456640-9C5E78C2-2F9E-470E-A563-DB55D250667A

Q34456640-9E331CB5-8C88-49F9-A590-41CFE64074E7

Q34456640-A0EE8F4C-4590-4E29-8A50-64555E51978E

Q34456640-B4BF6DEF-7FB0-4C84-B72B-5905923127FF

P304

Q34456640-CE02BA14-9C6D-4950-9579-A13D1809DBE1

P31

Q34456640-D9A96679-E097-4807-A653-33C3080859EE

P356

Q34456640-3AED7CB0-E38D-4551-A40D-EDD9B38A6002

P407

Q34456640-419C086B-E129-4CDC-811E-7E0DD97D1B02

P433

Q34456640-39805C56-53EB-4A9F-999E-0E2AA374AF0E

P478

Q34456640-3F174DAB-B384-4DF0-8A11-9030F2037A08

P577

Q34456640-7649440F-5121-4C19-89B4-AEF33C2C08FD

P5875

Q34456640-25C08BD1-8FAC-4CCE-A13F-6BC67E484220

P698

Q34456640-E09E7D73-B698-4D8C-BAF1-96E6101F0B9F

P356

1078-0432.CCR-05-0177

P1433

Clinical Cancer Research

P1476

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

@en

P2093

Ekaterini Blaveri

http://www.w3.org/2001/XMLSchema#string

Frederic M Waldman

http://www.w3.org/2001/XMLSchema#string

Jane Fridlyand

http://www.w3.org/2001/XMLSchema#string

Jeff P Simko

http://www.w3.org/2001/XMLSchema#string

Jeremy L Brewer

http://www.w3.org/2001/XMLSchema#string

Kshama Mehta

http://www.w3.org/2001/XMLSchema#string

Peter Carroll

http://www.w3.org/2001/XMLSchema#string

Ritu Roydasgupta

http://www.w3.org/2001/XMLSchema#string

Sandy DeVries

http://www.w3.org/2001/XMLSchema#string

Sunanda Pejavar

http://www.w3.org/2001/XMLSchema#string

P304

7012-7022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-05-0177

http://www.w3.org/2001/XMLSchema#string

P407

P433

19 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7561047

http://www.w3.org/2001/XMLSchema#string

P698

16203795

http://www.w3.org/2001/XMLSchema#string